Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
43,510,440
-
Total 13F shares
-
6,385,187
-
Share change
-
+488,104
-
Total reported value
-
$263,391,165
-
Price per share
-
$41.25
-
Number of holders
-
64
-
Value change
-
+$20,252,370
-
Number of buys
-
30
-
Number of sells
-
23
Institutional Holders of Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA) as of Q4 2025
As of 31 Dec 2025,
Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,385,187 shares.
The largest 10 holders included
VANGUARD GROUP INC, Pictet Asset Management Holding SA, SG Americas Securities, LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Aberdeen Group plc, PEREGRINE CAPITAL MANAGEMENT LLC, Linden Thomas Advisory Services, LLC, NORDEA INVESTMENT MANAGEMENT AB, Hennion & Walsh Asset Management, Inc., and UBS Group AG.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.